Elevance Health Statistics

Total Valuation

Elevance Health has a market cap or net worth of GBP 58.32 billion. The enterprise value is 74.85 billion.

Market Cap	58.32B
Enterprise Value	74.85B

Important Dates

The last earnings date was Wednesday, April 22, 2026.

Earnings Date	Apr 22, 2026
Ex-Dividend Date	Mar 10, 2026

Share Statistics

Current Share Class	217.16M
Shares Outstanding	n/a
Shares Change (YoY)	-3.57%
Shares Change (QoQ)	-0.63%
Owned by Insiders (%)	0.12%
Owned by Institutions (%)	96.18%
Float	216.66M

Valuation Ratios

The trailing PE ratio is 14.69 and the forward PE ratio is 14.03.

PE Ratio	14.69
Forward PE	14.03
PS Ratio	0.38
PB Ratio	1.75
P/TBV Ratio	17.23
P/FCF Ratio	11.94
P/OCF Ratio	10.13
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.64, with an EV/FCF ratio of 15.32.

EV / Earnings	18.85
EV / Sales	0.50
EV / EBITDA	11.64
EV / EBIT	12.93
EV / FCF	15.32

Financial Position

The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.72.

Current Ratio	1.48
Quick Ratio	1.33
Debt / Equity	0.72
Debt / EBITDA	3.67
Debt / FCF	4.94
Interest Coverage	5.52

Financial Efficiency

Return on equity (ROE) is 12.09% and return on invested capital (ROIC) is 8.63%.

Return on Equity (ROE)	12.09%
Return on Assets (ROA)	3.98%
Return on Invested Capital (ROIC)	8.63%
Return on Capital Employed (ROCE)	9.71%
Weighted Average Cost of Capital (WACC)	6.04%
Revenue Per Employee	1.57M
Profits Per Employee	41,097
Employee Count	96,615
Asset Turnover	1.63
Inventory Turnover	n/a

Taxes

In the past 12 months, Elevance Health has paid 742.16 million in taxes.

Income Tax	742.16M
Effective Tax Rate	15.76%

Stock Price Statistics

The stock price has decreased by -12.76% in the last 52 weeks. The beta is 0.50, so Elevance Health's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	-12.76%
50-Day Moving Average	311.20
200-Day Moving Average	324.80
Relative Strength Index (RSI)	77.88
Average Volume (20 Days)	447

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.24

Income Statement

In the last 12 months, Elevance Health had revenue of GBP 151.78 billion and earned 3.97 billion in profits. Earnings per share was 17.81.

Revenue	151.78B
Gross Profit	39.30B
Operating Income	5.92B
Pretax Income	4.71B
Net Income	3.97B
EBITDA	6.47B
EBIT	5.92B
Earnings Per Share (EPS)	17.81

Balance Sheet

The company has 28.08 billion in cash and 24.11 billion in debt, giving a net cash position of -16.80 billion.

Cash & Cash Equivalents	28.08B
Total Debt	24.11B
Net Cash	-16.80B
Net Cash Per Share	n/a
Equity (Book Value)	33.35B
Book Value Per Share	152.95
Working Capital	16.45B

Cash Flow

In the last 12 months, operating cash flow was 5.76 billion and capital expenditures -874.69 million, giving a free cash flow of 4.88 billion.

Operating Cash Flow	5.76B
Capital Expenditures	-874.69M
Depreciation & Amortization	n/a
Net Borrowing	1.36B
Free Cash Flow	4.88B
FCF Per Share	n/a

Margins

Gross margin is 25.89%, with operating and profit margins of 3.90% and 2.62%.

Gross Margin	25.89%
Operating Margin	3.90%
Pretax Margin	3.10%
Profit Margin	2.62%
EBITDA Margin	4.26%
EBIT Margin	3.90%
FCF Margin	3.22%

Dividends & Yields

This stock pays an annual dividend of 5.09, which amounts to a dividend yield of 1.43%.

Dividend Per Share	5.09
Dividend Yield	1.43%
Dividend Growth (YoY)	-0.84%
Years of Dividend Growth	8
Payout Ratio	28.97%
Buyback Yield	3.57%
Shareholder Yield	5.00%
Earnings Yield	6.81%
FCF Yield	8.38%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6